Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €97.90 by JPMorgan Chase & Co.

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €97.90 ($113.84) price target by JPMorgan Chase & Co. in a report released on Tuesday, October 30th. The firm currently has a “buy” rating on the stock. JPMorgan Chase & Co.’s target price indicates a potential upside of 41.03% from the stock’s previous close.

Several other research analysts also recently commented on FME. Morgan Stanley set a €93.00 ($108.14) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Tuesday, July 3rd. Credit Suisse Group set a €91.00 ($105.81) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Wednesday, July 4th. Nord/LB set a €102.00 ($118.60) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, July 6th. Bank of America set a €102.00 ($118.60) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, July 10th. Finally, Berenberg Bank set a €100.80 ($117.21) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Thursday, July 12th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of €89.64 ($104.23).

Shares of FME stock traded up €1.24 ($1.44) during trading hours on Tuesday, hitting €69.42 ($80.72). 711,470 shares of the company’s stock were exchanged, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €75.53 ($87.83) and a 12-month high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Featured Article: Trading Strategy Methods and Types

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply